In a significant development for the cannabis industry, U.S. health officials have recommended easing restrictions on cannabis and reclassifying it as a Schedule III drug...
Food and Drug Administration (FDA) Deputy Commissioner for Food Policy and Response Frank Yiannas said the in-progress rule changes at the agency are likely to...